Reading Time: < 1 minute
International
-Multiple senior U.S. officials disclosed that U.S. President Trump is expected to decide within the next few days whether to escalate military operations against Iran and resume full-scale combat operations.
Sectors
-According to the National Medical Products Administration (NMPA), an innovative new-target drug developed and filed for approval globally in parallel was the first to receive marketing authorization in China today. This marks a historic breakthrough for original innovative drugs with novel targets developed through global multi-center trials to achieve first filing and first launch in China.
-According to the National Health Commission of China, as of the present, 27.51 million applications for the 2026 childcare subsidies have been submitted, of which 27.13 million have been approved and subsidies have been issued to 25.16 million individuals.
Industry
-Sources said Xiaomi has raised its full-year smartphone shipment target for 2026 from around 90 million units to 110 million units, representing an increase of roughly 16%.
Jul 21 Block Trade Info
*Discount
-Gigadevice Semiconductor (603986 CH) saw 3 block trades worth 576.29mn at 419.33yuan per share, 3.00pct discount from last closing.
-Kweichow Moutai (600519 CH) saw 1 block trades worth 168.28mn at 1318.81yuan per share, 0.65pct discount from last closing.
*Premium
-Eastroc Beverage (605499 CH) saw 1 block trades worth 167.85mn at 130.54yuan per share, 3.14pct premium from last closing.
For more insights, please visit Orient Futures Singapore’s research platform,
Finoview.

